2023
Real-World Diabetes Technology: Overcoming Barriers and Disparities
Messer L, Addala A, Weinzimer S. Real-World Diabetes Technology: Overcoming Barriers and Disparities. Diabetes Technology & Therapeutics 2023, 25: s-176-s-190. PMID: 36802191, DOI: 10.1089/dia.2023.2511.Peer-Reviewed Original Research
2022
Navigating barriers to affording and obtaining insulin and diabetes supplies
Wilcox A, Lipska K, Weinzimer S, Gujral J, Arakaki A, Kerandi L, Nally L. Navigating barriers to affording and obtaining insulin and diabetes supplies. Journal Of Diabetes 2022, 15: 71-75. PMID: 36562281, PMCID: PMC9870729, DOI: 10.1111/1753-0407.13344.Peer-Reviewed Original Research
2021
Practical Diabetes Technology: Overcoming Barriers in the Real World
Messer LH, Weinzimer SA. Practical Diabetes Technology: Overcoming Barriers in the Real World. Diabetes Technology & Therapeutics 2021, 23: s-159-s-168. PMID: 34061638, DOI: 10.1089/dia.2021.2511.Peer-Reviewed Original ResearchDiabetes MellitusHumans
2020
Transformations: What I Learned Along My Patient’s Gender Journey
Weinzimer SA. Transformations: What I Learned Along My Patient’s Gender Journey. Pediatrics 2020, 146: e20200756. PMID: 33028662, DOI: 10.1542/peds.2020-0756.Peer-Reviewed Original ResearchPractical Implementation of Diabetes Technology: Real‐World Use
Messer LH, Weinzimer SA. Practical Implementation of Diabetes Technology: Real‐World Use. Diabetes Technology & Therapeutics 2020, 22: s-119-s-129. PMID: 32069150, PMCID: PMC7869873, DOI: 10.1089/dia.2020.2509.Peer-Reviewed Original Research
2019
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, Bosi E, Buckingham BA, Cefalu WT, Close KL, Cobelli C, Dassau E, DeVries JH, Donaghue KC, Dovc K, Doyle FJ, Garg S, Grunberger G, Heller S, Heinemann L, Hirsch IB, Hovorka R, Jia W, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Levine B, Mayorov A, Mathieu C, Murphy HR, Nimri R, Nørgaard K, Parkin CG, Renard E, Rodbard D, Saboo B, Schatz D, Stoner K, Urakami T, Weinzimer SA, Phillip M. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care 2019, 42: 1593-1603. PMID: 31177185, PMCID: PMC6973648, DOI: 10.2337/dci19-0028.Peer-Reviewed Original Research
2017
The dawn of automated insulin delivery: A new clinical framework to conceptualize insulin administration
Messer LH, Forlenza GP, Wadwa RP, Weinzimer SA, Sherr JL, Hood KK, Buckingham BA, Slover RH, Maahs DM. The dawn of automated insulin delivery: A new clinical framework to conceptualize insulin administration. Pediatric Diabetes 2017, 19: 14-17. PMID: 28656656, DOI: 10.1111/pedi.12535.Peer-Reviewed Original ResearchMeSH KeywordsDiabetes MellitusHumansHypoglycemic AgentsInsulinInsulin Infusion SystemsPancreas, Artificial
2003
Body composition and metabolic factors in obese children and adolescents
Tershakovec AM, Kuppler KM, Zemel BS, Katz L, Weinzimer S, Harty MP, Stallings VA. Body composition and metabolic factors in obese children and adolescents. International Journal Of Obesity 2003, 27: 19-24. PMID: 12532149, DOI: 10.1038/sj.ijo.0802185.Peer-Reviewed Original ResearchConceptsVisceral abdominal fatSubcutaneous abdominal fatLeptin levelsInsulin levelsFat massObese childrenAbdominal fatBody compositionHOMA-IRInsulin resistanceMetabolic factorsTotal body fat massDual-energy X-ray absorptiometryEnergy X-ray absorptiometryHigher HOMA-IRHomeostasis model assessmentNon-obese childrenHigher insulin levelsBody fat massTotal body fatGroup differencesRegional fat distributionCross-sectional assessmentX-ray absorptiometryLow glucose levels